Related references
Note: Only part of the references are listed.Topiramate for alcoholism treatment: novel pharmacogenetic evidence for the journey to personalized medicine?
Lorenzo Leggio et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Use of Novel Technology-Based Techniques to Improve Alcohol-Related Outcomes in Clinical Trials
Eugenia M. Gurvich et al.
ALCOHOL AND ALCOHOLISM (2013)
The 1-Adrenergic Receptor Antagonist, Doxazosin, Reduces Alcohol Drinking in Alcohol-Preferring (P) Rats
Meghan L. O'Neil et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2013)
Assessment of riboflavin as a tracer substance: Comparison of a qualitative to a quantitative method of riboflavin measurement
Abigail J. Herron et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: A pilot study
D. Shorter et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Prazosin Effects on Stress- and Cue-Induced Craving and Stress Response in Alcohol-Dependent Individuals: Preliminary Findings
Helen C. Fox et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2012)
Noradrenergic α1 Receptor Antagonist Treatment Attenuates Positive Subjective Effects of Cocaine in Humans: A Randomized Trial
Thomas F. Newton et al.
PLOS ONE (2012)
When Can Categorical Variables Be Treated as Continuous? A Comparison of Robust Continuous and Categorical SEM Estimation Methods Under Suboptimal Conditions
Mijke Rhemtulla et al.
PSYCHOLOGICAL METHODS (2012)
Does Family History of Alcoholism Moderate Naltrexone's Effects on Alcohol Use?
Christy Capone et al.
JOURNAL OF STUDIES ON ALCOHOL AND DRUGS (2011)
Pharmacogenetic approaches to the treatment of alcohol addiction
Markus Heilig et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Effect of prazosin and guanfacine on stress-induced reinstatement of alcohol and food seeking in rats
A. D. Le et al.
PSYCHOPHARMACOLOGY (2011)
Percentage of Subjects With No Heavy Drinking Days: Evaluation as an Efficacy Endpoint for Alcohol Clinical Trials
Daniel Falk et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2010)
Doxazosin Treatment for Posttraumatic Stress Disorder
Joop De Jong et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2010)
Orexin-1 receptor antagonism decreases ethanol consumption and preference selectively in high-ethanol-preferring Sprague-Dawley rats
David E. Moorman et al.
ALCOHOL (2009)
The α1-Adrenergic Receptor Antagonist, Prazosin, Reduces Alcohol Drinking in Alcohol-Preferring (P) Rats
Dennis D. Rasmussen et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2009)
A Pilot Trial of the Alpha-1 Adrenergic Antagonist, Prazosin, for Alcohol Dependence
Tracy L. Simpson et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2009)
Typologies of Alcohol Dependence. From Jellinek to Genetics and Beyond
Lorenzo Leggio et al.
NEUROPSYCHOLOGY REVIEW (2009)
α1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol
Brendan M. Walker et al.
ALCOHOL (2008)
Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension
Amy I. Lynch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Family history and antisocial traits moderate naltrexone's effects on heavy drinking in alcoholics
Damaris J. Rohsenow et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2007)
Combined pharmacotherapies and behavioral interventions for alcohol dependence - The COMBINE study: A randomized controlled trial
RF Anton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Acoustic startle reactivity during acute alcohol withdrawal in rats that differ in genetic predisposition toward alcohol drinking: Effect of stimulus characteristics
JA Chester et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2004)
Differences in peripheral noradrenergic function among actively drinking and abstinent alcohol-dependent individuals
AA Patkar et al.
AMERICAN JOURNAL ON ADDICTIONS (2004)
Terazosin, doxazosin, and prazosin: Current clinical experience
B Akduman et al.
UROLOGY (2001)